Alphatec Holdings, Inc. (ATEC)
USD 10.01
(-1.96%)
USD 10.01
(-1.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 805.2 Million USD | 56.85% |
| 2022 | 513.37 Million USD | -10.26% |
| 2021 | 572.05 Million USD | 118.99% |
| 2020 | 261.22 Million USD | 53.71% |
| 2019 | 169.94 Million USD | 31.26% |
| 2018 | 129.47 Million USD | 52.94% |
| 2017 | 84.66 Million USD | -10.12% |
| 2016 | 94.18 Million USD | -35.8% |
| 2015 | 146.7 Million USD | -57.47% |
| 2014 | 344.92 Million USD | -5.66% |
| 2013 | 365.63 Million USD | -4.32% |
| 2012 | 382.12 Million USD | 4.21% |
| 2011 | 366.69 Million USD | -2.74% |
| 2010 | 377.01 Million USD | 132.89% |
| 2009 | 161.88 Million USD | 4.08% |
| 2008 | 155.54 Million USD | 5.64% |
| 2007 | 147.24 Million USD | 13.89% |
| 2006 | 129.27 Million USD | 18.45% |
| 2005 | 109.13 Million USD | 865.28% |
| 2004 | 11.3 Million USD | 0.0% |
| 2002 | 7.08 Million USD | -23.13% |
| 2001 | 9.21 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 768.58 Million USD | -0.77% |
| 2024 Q1 | 774.58 Million USD | -3.8% |
| 2024 Q3 | 745.89 Million USD | -2.95% |
| 2023 FY | 805.2 Million USD | 56.85% |
| 2023 Q4 | 805.2 Million USD | 20.14% |
| 2023 Q3 | 670.22 Million USD | 6.68% |
| 2023 Q2 | 628.23 Million USD | 10.28% |
| 2023 Q1 | 569.69 Million USD | 10.97% |
| 2022 Q3 | 516.28 Million USD | 0.85% |
| 2022 Q2 | 511.93 Million USD | -6.7% |
| 2022 Q4 | 513.37 Million USD | -0.56% |
| 2022 FY | 513.37 Million USD | -10.26% |
| 2022 Q1 | 548.68 Million USD | -4.08% |
| 2021 FY | 572.05 Million USD | 118.99% |
| 2021 Q1 | 404.5 Million USD | 54.85% |
| 2021 Q2 | 441.02 Million USD | 9.03% |
| 2021 Q3 | 598.1 Million USD | 35.62% |
| 2021 Q4 | 572.05 Million USD | -4.36% |
| 2020 Q4 | 261.22 Million USD | 68.88% |
| 2020 Q3 | 154.67 Million USD | -4.01% |
| 2020 FY | 261.22 Million USD | 53.71% |
| 2020 Q1 | 153.83 Million USD | -9.48% |
| 2020 Q2 | 161.13 Million USD | 4.74% |
| 2019 Q2 | 133.43 Million USD | 11.74% |
| 2019 FY | 169.94 Million USD | 31.26% |
| 2019 Q4 | 169.94 Million USD | -4.68% |
| 2019 Q3 | 178.28 Million USD | 33.61% |
| 2019 Q1 | 119.41 Million USD | -7.77% |
| 2018 Q3 | 131.46 Million USD | -5.76% |
| 2018 Q2 | 139.49 Million USD | -2.68% |
| 2018 Q1 | 143.33 Million USD | 69.31% |
| 2018 Q4 | 129.47 Million USD | -1.51% |
| 2018 FY | 129.47 Million USD | 52.94% |
| 2017 Q1 | 93.57 Million USD | -0.66% |
| 2017 FY | 84.66 Million USD | -10.12% |
| 2017 Q4 | 84.66 Million USD | 6.13% |
| 2017 Q3 | 79.77 Million USD | -5.25% |
| 2017 Q2 | 84.19 Million USD | -10.02% |
| 2016 Q3 | 96.02 Million USD | -29.63% |
| 2016 Q2 | 136.45 Million USD | -6.15% |
| 2016 Q1 | 145.39 Million USD | -0.9% |
| 2016 FY | 94.18 Million USD | -35.8% |
| 2016 Q4 | 94.18 Million USD | -1.91% |
| 2015 Q3 | 148.38 Million USD | -52.77% |
| 2015 Q1 | 320.1 Million USD | -7.19% |
| 2015 FY | 146.7 Million USD | -57.47% |
| 2015 Q4 | 146.7 Million USD | -1.13% |
| 2015 Q2 | 314.17 Million USD | -1.85% |
| 2014 Q1 | 386.28 Million USD | 5.65% |
| 2014 FY | 344.92 Million USD | -5.66% |
| 2014 Q4 | 344.92 Million USD | -1.06% |
| 2014 Q3 | 348.6 Million USD | -4.42% |
| 2014 Q2 | 364.71 Million USD | -5.58% |
| 2013 Q3 | 366.13 Million USD | -0.15% |
| 2013 FY | 365.63 Million USD | -4.32% |
| 2013 Q2 | 366.67 Million USD | -2.01% |
| 2013 Q1 | 374.19 Million USD | -2.07% |
| 2013 Q4 | 365.63 Million USD | -0.14% |
| 2012 Q3 | 365.66 Million USD | 2.41% |
| 2012 Q4 | 382.12 Million USD | 4.5% |
| 2012 FY | 382.12 Million USD | 4.21% |
| 2012 Q1 | 364.68 Million USD | -0.55% |
| 2012 Q2 | 357.05 Million USD | -2.09% |
| 2011 Q4 | 366.69 Million USD | -1.61% |
| 2011 FY | 366.69 Million USD | -2.74% |
| 2011 Q1 | 388.73 Million USD | 3.11% |
| 2011 Q2 | 384.44 Million USD | -1.1% |
| 2011 Q3 | 372.69 Million USD | -3.06% |
| 2010 Q2 | 374.69 Million USD | 4.9% |
| 2010 FY | 377.01 Million USD | 132.89% |
| 2010 Q1 | 357.2 Million USD | 120.65% |
| 2010 Q4 | 377.01 Million USD | -3.43% |
| 2010 Q3 | 390.39 Million USD | 4.19% |
| 2009 Q1 | 158.23 Million USD | 1.73% |
| 2009 Q4 | 161.88 Million USD | -1.47% |
| 2009 Q3 | 164.3 Million USD | -2.84% |
| 2009 FY | 161.88 Million USD | 4.08% |
| 2009 Q2 | 169.11 Million USD | 6.88% |
| 2008 FY | 155.54 Million USD | 5.64% |
| 2008 Q4 | 155.54 Million USD | 5.75% |
| 2008 Q3 | 147.09 Million USD | 4.2% |
| 2008 Q2 | 141.16 Million USD | -6.09% |
| 2008 Q1 | 150.32 Million USD | 2.09% |
| 2007 Q3 | 156.74 Million USD | 23.93% |
| 2007 FY | 147.24 Million USD | 13.89% |
| 2007 Q1 | 124.06 Million USD | -4.03% |
| 2007 Q2 | 126.47 Million USD | 1.94% |
| 2007 Q4 | 147.24 Million USD | -6.06% |
| 2006 Q1 | 115.72 Million USD | 6.03% |
| 2006 FY | 129.27 Million USD | 18.45% |
| 2006 Q2 | 139.47 Million USD | 20.53% |
| 2006 Q3 | 131.4 Million USD | -5.79% |
| 2006 Q4 | 129.27 Million USD | -1.62% |
| 2005 FY | 109.13 Million USD | 865.28% |
| 2005 Q4 | 109.13 Million USD | 0.0% |
| 2004 Q4 | 11.3 Million USD | 0.0% |
| 2004 FY | 11.3 Million USD | 0.0% |
| 2002 FY | 7.08 Million USD | -23.13% |
| 2001 FY | 9.21 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -2467.136% |
| BrainsWay Ltd. | 62.97 Million USD | -1178.676% |
| Cerus Corporation | 197.74 Million USD | -307.189% |
| Envoy Medical, Inc. | 7.64 Million USD | -10439.372% |
| electroCore, Inc. | 16.38 Million USD | -4813.7% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -10368.123% |
| IceCure Medical Ltd | 16.41 Million USD | -4806.813% |
| Inogen, Inc. | 326.19 Million USD | -146.849% |
| OrthoPediatrics Corp. | 449.58 Million USD | -79.1% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -2852.725% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -4756.792% |
| MaxCyte, Inc. | 268.27 Million USD | -200.144% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -9844.137% |
| Nexalin Technology, Inc. | 3.63 Million USD | -22070.337% |
| Orthofix Medical Inc. | 925.31 Million USD | 12.98% |
| PAVmed Inc | 33.11 Million USD | -2331.257% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -461.308% |
| RxSight, Inc. | 182.55 Million USD | -341.089% |
| Sight Sciences, Inc. | 166.65 Million USD | -383.17% |
| SI-BONE, Inc. | 230.42 Million USD | -249.445% |
| TELA Bio, Inc. | 78.04 Million USD | -931.683% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -219.645% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -7404.268% |
| Acutus Medical, Inc. | 53.96 Million USD | -1392.231% |
| Talis Biomedical Corporation | 98.34 Million USD | -718.8% |
| Spectral AI, Inc. | 10.69 Million USD | -7430.939% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -268.267% |
| CVRx, Inc. | 115.22 Million USD | -598.789% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -1272.646% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -25747.275% |
| Bioventus Inc. | 810.91 Million USD | 0.703% |
| Venus Concept Inc. | 93.65 Million USD | -759.769% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -3030.06% |
| LivaNova PLC | 2.42 Billion USD | 66.858% |
| 908 Devices Inc. | 202.98 Million USD | -296.691% |
| Nemaura Medical Inc. | 14.56 Million USD | -5429.047% |
| NeuroPace, Inc. | 107.65 Million USD | -647.98% |
| LENSAR, Inc. | 69.58 Million USD | -1057.157% |
| Apyx Medical Corporation | 79.24 Million USD | -916.164% |
| Cutera, Inc. | 346.29 Million USD | -132.524% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -1816.432% |
| BioSig Technologies, Inc. | 1.79 Million USD | -44683.537% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -197.529% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -1787.457% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 78.709% |
| Axonics, Inc. | 719.92 Million USD | -11.846% |
| Outset Medical, Inc. | 313.8 Million USD | -156.598% |
| IRIDEX Corporation | 34.43 Million USD | -2238.274% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -98.956% |
| IRadimed Corporation | 92.15 Million USD | -773.744% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -15225.619% |
| INVO Bioscience, Inc. | 20.88 Million USD | -3754.922% |
| Telesis Bio, Inc. | 70.41 Million USD | -1043.583% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -422.515% |
| Varex Imaging Corporation | 1.24 Billion USD | 35.563% |
| Quipt Home Medical Corp. | 247.4 Million USD | -225.458% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -8548.851% |
| Pulmonx Corporation | 178.95 Million USD | -349.96% |
| Dynatronics Corporation | 25.94 Million USD | -3004.05% |
| Modular Medical, Inc. | 13.8 Million USD | -5731.882% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -7406.367% |
| Semler Scientific, Inc. | 78.06 Million USD | -931.458% |
| InMode Ltd. | 863.28 Million USD | 6.728% |
| Bruker Corporation | 4.24 Billion USD | 81.053% |
| Cytosorbents Corporation | 53.26 Million USD | -1411.826% |
| DexCom, Inc. | 6.26 Billion USD | 87.146% |
| Align Technology, Inc. | 6.08 Billion USD | 86.765% |
| Viveve Medical, Inc. | 25.91 Million USD | -3007.352% |
| ZimVie Inc. | 1.2 Billion USD | 33.197% |
| Movano Inc. | 9.42 Million USD | -8446.948% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -61.796% |
| Nexalin Technology, Inc. | 3.63 Million USD | -22070.337% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -1272.646% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 15.478% |
| Profound Medical Corp. | 43.68 Million USD | -1743.157% |
| Insulet Corporation | 2.58 Billion USD | 68.889% |
| enVVeno Medical Corporation | 48.63 Million USD | -1555.614% |
| Surmodics, Inc. | 185.73 Million USD | -333.53% |
| iCAD, Inc. | 41.41 Million USD | -1844.102% |
| Nuwellis, Inc. | 9.77 Million USD | -8141.638% |
| Biotricity, Inc. | 5.94 Million USD | -13449.702% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -85.898% |
| Aethlon Medical, Inc. | 8.24 Million USD | -9664.853% |
| InspireMD, Inc. | 47.64 Million USD | -1590.087% |
| PAVmed Inc. | 33.11 Million USD | -2331.257% |
| BIOLASE, Inc. | 35.1 Million USD | -2193.975% |
| Beyond Air, Inc. | 56.96 Million USD | -1313.613% |
| FONAR Corporation | 214.24 Million USD | -275.833% |
| AxoGen, Inc. | 196.82 Million USD | -309.094% |
| Vivani Medical, Inc. | 45.79 Million USD | -1658.211% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -186.105% |
| Inari Medical, Inc. | 674.23 Million USD | -19.425% |
| UFP Technologies, Inc. | 404.13 Million USD | -99.242% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -3341.271% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -8373.097% |
| Tenon Medical, Inc. | 6.34 Million USD | -12590.433% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -8459.668% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -676.87% |
| AdaptHealth Corp. | 4.61 Billion USD | 82.571% |
| Sintx Technologies, Inc. | 15.36 Million USD | -5140.534% |
| NanoVibronix, Inc. | 6.67 Million USD | -11964.849% |
| Quanterix Corporation | 425.01 Million USD | -89.456% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -8548.851% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -1398.703% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 53.883% |
| TransMedics Group, Inc. | 706.04 Million USD | -14.045% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -1174.225% |
| NeuroMetrix, Inc. | 21.42 Million USD | -3658.362% |
| Hyperfine, Inc. | 94.19 Million USD | -754.795% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -199.734% |
| Biomerica, Inc. | 9.25 Million USD | -8601.189% |
| Bone Biologics Corporation | 3.73 Million USD | -21442.511% |
| AVITA Medical, Inc. | 144.33 Million USD | -457.855% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -16439.034% |
| Silk Road Medical, Inc | 265.3 Million USD | -203.498% |